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ABSTRACT
BACKGROUND AND PURPOSE: Normal biometry of the fetal posterior fossa rules out most major anomalies of the cerebellum and
vermis. Our aim was to provide new reference data of the fetal vermis in 4 biometric parameters by using 3 imaging modalities, 2D
ultrasound, 3D ultrasound, and MR imaging, and to assess the relation among these modalities.
MATERIALS AND METHODS: A retrospective study was conducted between June 2011 and June 2013. Three different imaging modalities were
used to measure vermis biometry: 2D ultrasound, 3D ultrasound, and MR imaging. The vermian parameters evaluated were the maximum
superoinferior diameter, maximum anteroposterior diameter, the perimeter, and the surface area. Statistical analysis was performed to calculate
centiles for gestational age and to assess the agreement among the 3 imaging modalities.
RESULTS: The number of fetuses in the study group was 193, 172, and 151 for 2D ultrasound, 3D ultrasound, and MR imaging,
respectively. The mean and median gestational ages were 29.1 weeks, 29.5 weeks (range, 21–35 weeks); 28.2 weeks, 29.05 weeks (range,
21–35 weeks); and 32.1 weeks, 32.6 weeks (range, 27–35 weeks) for 2D ultrasound, 3D ultrasound, and MR imaging, respectively. In all
3 modalities, the biometric measurements of the vermis have shown a linear growth with gestational age. For all 4 biometric
parameters, the lowest results were those measured by MR imaging, while the highest results were measured by 3D ultrasound. The
inter- and intraobserver agreement was excellent for all measures and all imaging modalities. Limits of agreement were considered
acceptable for clinical purposes for all parameters, with excellent or substantial agreement defined by the intraclass correlation
coefficient.
CONCLUSIONS: Imaging technique–specific reference data should be used for the assessment of the fetal vermis in pregnancy.
ABBREVIATIONS: AP  anteroposterior; ICC  intraclass correlation coefficient; SA  surface area; SI  superoinferior; US  ultrasound; VCI  volume contrast
imaging
Imaging of the fetal posterior fossa is considered a routine partof the fetal sonographic examination. Normal sonographic
biometry and normal morphology of the posterior fossa rule
out most major anomalies of the fetal cerebellum and vermis.1
However, in case of an abnormal posterior fossa, evaluation of
the vermian biometry and morphology is of paramount im-
portance, considering the wide clinical spectrum of this imag-
ing finding.2
Fetal posterior fossa anomalies range from benign asymptom-
atic conditions to severe abnormalities associated with neurologic
impairment.3-6 The most frequent of these anomalies, Blakes
pouch cyst, vermian hypoplasia, and Dandy-Walker malforma-
tion, have a similar imaging appearance7,8 but different vermian
biometry and, therefore, different prognoses.9
Many anomalies of the posterior fossa can be depicted with
sonography alone.10 Although the standard axial imaging planes
may detect most anomalies of the posterior fossa, the diagnosis of
the exact type of abnormality might be challenging because a clear
visualization of the midsagittal plane is essential. Subtle changes
in the morphology of the vermis are hidden by this axial view, and
this feature can lead to false-positive diagnoses of vermian
pathologies.11,12
Our group has proposed using the transabdominal sagittal
plane for visualization of the fetal vermis,13 while Malinger et al14
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reported their experience with the transvaginal approach. Vinals
et al15 used volume contrast imaging (VCI) on plane C to con-
struct nomograms for the normal fetal vermis. Our group used
this same VCI on plane C technique to compare normal and ab-
normal fetal vermis measurements, and we concluded that the 3D
sonographic technique has many advantages in the detection of
posterior fossa anomalies.16 It allows off-line evaluation and re-
construction of images, even with abnormal angles when the mid-
sagittal plane is difficult to obtain.
MR imaging is a well-known complementary tool in the pre-
natal diagnosis of fetal brain abnormalities. The challenges de-
scribed above in achieving a good visualization of the midsagittal
plane in prenatal sonography led to frequent use of this tool to
assess, more accurately, the structures of the posterior fossa and
improve prenatal diagnosis.
Various nomograms have been developed to establish
normal biometric measures of the fetal vermis by using ultra-
sound (US) or MR imaging.17-19 None of these nomograms
provided data regarding all 4 vermian biometric parameters.
Moreover, there were no comparisons among all 3 imaging
modalities.20
The aims of our study were the following: to provide normal
reference biometric data of the fetal vermis in 4 biometric param-
eters for 3 imaging modalities, to evaluate the reproducibility of
the vermian biometry, and to compare the measurements ob-
tained by 2D sonography, 3D sonography, and MR imaging.
MATERIALS AND METHODS
Population
A retrospective study was conducted between June 2011 and June
2013.
All sonographic examinations were performed during rou-
tine pregnancy follow-up and were in addition to the standard
axial views. MR imaging examinations were performed due to
increased risk of suspected cerebral pathology, including sus-
pected infectious fetopathy, suspected sonographic cerebral
abnormality, positive family history, a previous pregnancy
with CNS abnormality, decreased fetal movements, polyhy-
dramnios, and extracranial anomalies such as club foot, cleft
lip, and/or palate. However, there was no evidence of intracra-
nial abnormalities.
The inclusion criteria for
the 3 groups were the follow-
ing: singleton pregnancy,
good dating, estimated fetal
weight within the 10th to 90th
percentiles, normal obstetric
course (no evidence of intra-
uterine growth restriction or
macrosomia or pregnancy-re-
lated hypertensive disorders
or gestational diabetes melli-
tus), absence of maternal dis-
ease (healthy women without
any background illness such
as hypercoagulability state,
hypertension, diabetes, or
other systemic disease), clini-
cally normal fetus at birth
(normal Apgar scores at birth,
normal neonate physical ex-
amination findings), and no
known neurologic family his-
tory. A detailed sonographic
scan was performed to rule out
fetal malformations. Only 1
measurement was used for each
patient with each gestational
week in each imaging technique.
FIG 1. Magnification of the fetal posterior fossa and vermis and dem-
onstration of biometric parameters. 1) Maximum superoinferior diam-
eter. 2) Anteroposterior diameter. 3) Perimeter and surface area.
FIG 2. Midsagittal view of the fetal brain demonstrating the vermis. A, 2D US. B, 3D US. C, MR imaging.
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US 2D US 3D MRI
%5 Median %95 %5 Median %95 %5 Median %95
21 10.69 11.95 12.57 11.10 12.30 14.60
22 10.42 12.72 14.40 11.50 13.60 14.90
23 11.71 12.79 13.84 13.00 14.40 16.50
24 13.33 13.79 14.82 13.40 15.35 17.50
25 13.85 15.17 16.66 14.50 16.00 17.80
26 13.75 16.09 18.45 15.60 16.80 19.50
27 14.05 17.07 18.78 16.70 18.70 20.20 13.30 14.13 15.05
28 16.08 17.09 19.72 16.30 18.80 23.80 13.66 14.58 15.73
29 17.29 18.72 20.33 18.10 20.00 22.20 13.25 16.02 17.54
30 17.83 18.56 19.62 18.40 20.50 23.60 15.77 17.38 20.76
31 18.03 19.34 20.75 18.10 21.30 23.80 16.16 18.02 19.34
32 17.68 19.33 20.59 19.00 21.40 26.60 16.75 18.67 20.12
33 16.78 20.93 22.94 20.70 22.70 24.50 18.37 19.48 21.21
34 19.11 20.38 23.34 20.40 22.30 28.50 17.90 19.56 21.30
35 19.62 21.75 24.29 20.90 22.00 27.00 18.27 19.83 23.29
Note:—%5 indicates 5th percentile; %95, 95th percentile.




US 2D US 3D MRI
%5 Median %95 %5 Median %95 %5 Median %95
21 7.08 7.79 8.71 5.70 8.10 10.30
22 7.51 9.51 10.62 7.40 9.15 12.40
23 7.27 8.72 10.25 6.30 8.80 11.00
24 8.96 9.49 10.64 8.60 9.85 11.00
25 9.58 10.73 13.17 9.90 10.50 14.60
26 8.76 11.28 14.17 8.10 11.30 12.80
27 10.06 11.44 12.69 9.30 12.50 14.80 9.11 9.33 11.10
28 10.75 12.32 14.94 9.20 12.30 15.90 8.90 9.97 12.04
29 10.09 12.61 15.01 11.20 12.80 14.40 8.93 11.05 13.28
30 11.06 13.36 14.94 10.70 13.70 16.80 10.39 11.92 15.01
31 12.69 14.01 15.81 11.80 14.60 18.00 11.07 12.30 13.96
32 11.93 13.87 17.38 10.70 15.20 18.40 11.40 13.04 13.90
33 12.63 15.11 17.83 11.80 13.05 19.70 11.91 13.26 15.22
34 12.36 15.94 17.82 12.00 15.60 21.40 11.18 13.77 15.10
35 13.84 16.40 17.40 12.60 15.75 18.90 12.70 14.83 17.17
Note:—%5 indicates 5th percentile; %95, 95th percentile.




US 2D US 3D MRI
%5 Median %95 %5 Median %95 %5 Median %95
21 36.20 40.94 44.80 37.20 41.70 54.60
22 37.04 46.80 48.64 40.60 47.30 49.40
23 41.20 45.07 49.39 41.50 46.90 55.20
24 48.10 49.89 51.80 45.00 49.20 56.70
25 46.74 52.41 62.86 48.80 53.30 63.30
26 50.00 57.87 65.98 50.80 58.30 68.60
27 48.97 59.08 67.10 51.40 64.00 69.30 50.05 50.67 57.75
28 53.26 60.42 69.40 57.60 66.20 82.60 48.22 53.30 58.16
29 58.58 65.42 69.37 58.80 66.40 77.20 50.58 56.85 61.09
30 60.08 64.98 70.36 57.80 70.20 82.80 55.07 61.10 72.13
31 61.18 65.67 71.97 64.10 71.10 82.40 59.38 66.21 71.93
32 62.13 67.31 77.88 65.30 74.60 96.10 61.20 68.11 73.79
33 68.13 71.38 76.83 73.70 77.95 82.50 64.98 70.90 78.33
34 67.05 73.97 80.43 66.50 80.10 92.80 67.21 71.06 83.00
35 70.20 75.19 79.16 68.50 79.70 100.20 69.44 75.93 86.11
Note:—%5 indicates 5th percentile; %95, 95th percentile.
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FIG 3. Comparison of measurements (mean  SD, 95% CI) obtained by 2D US, 3D US, and MR imaging. A, SI. B, AP. C, Perimeter. D, SA.




US 2D US 3D MRI
%5 Median %95 %5 Median %95 %5 Median %95
21 82.41 99.27 112.76 70.00 98.00 126.00
22 92.43 114.88 131.10 95.00 125.00 141.00
23 100.38 125.18 146.12 92.00 119.00 164.00
24 130.89 138.14 154.26 118.00 140.50 175.00
25 135.91 170.76 198.12 127.00 155.00 233.00
26 139.84 189.49 234.09 150.00 193.00 215.00
27 158.35 198.22 234.51 176.00 223.00 255.00 127.08 143.50 152.34
28 182.56 222.26 293.91 177.00 218.00 376.00 132.66 157.32 176.64
29 215.82 246.64 293.68 199.00 235.00 319.00 140.89 175.90 204.92
30 228.12 255.40 282.77 223.00 286.00 330.00 170.35 196.48 251.86
31 240.25 268.21 299.06 219.00 298.00 355.00 181.44 214.24 239.03
32 241.17 282.90 330.94 263.00 297.00 412.00 202.60 229.60 272.65
33 274.90 325.12 370.45 295.00 308.00 383.00 207.49 246.18 266.11
34 283.93 340.38 405.17 256.00 327.00 540.00 224.95 246.21 322.73
35 302.87 350.00 392.47 280.00 323.00 478.00 242.75 279.97 363.32
Note:—%5 indicates 5th percentile; %95, 95th percentile.
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The measurements of vermian parameters were performed
according to the following anatomic landmarks: 1) The maxi-
mum superoinferior (SI) diameter, the greatest height of the ver-
mis, which is generally parallel to the axis of the brain stem; 2)
maximum anteroposterior (AP) diameter from the peak of the
fourth ventricle, the fastigium, to the maximal AP diameter; 3)
perimeter, the track line that follows vermian fissures; and 4) sur-
face area, the same peripheral line that calculates surface area. All
4 parameters of the fetal vermis were measured at the same land-
marks for each technique (Fig 1).
For each study group, all measurements were performed by
a single operator. To evaluate the reproducibility of measure-
ments, an arbitrary sample of 50 fetuses was evaluated twice by
the first operator and then by a second operator. Each operator
was unaware of the results obtained by the other.
Imaging Technique and Measurements
Sonography. All patients were scanned by using a Voluson 730
Expert or a Voluson E8 (GE Medical Systems, Kretz Ultrasound,
Zipf, Austria) with a transabdominal transducer of 4 – 8 MHz or a
5- to 9-MHz transvaginal probe.
2D Technique. The fetal brain was scanned in a midsagittal plane
by using the transfontanel approach. A true midsagittal image of
the entire vermis is defined as a plane of a section that passes
through the rostral and caudal convexities at the levels of the
superior, middle, and inferior portion of the vermis. The fasti-
gium should be visualized in this plane.
According to Achiron et al,13 the midsagittal view includes the
corpus callosum, the cavum septi pellucidi, and the brain stem–
vermis plane. At the brain stem–vermis level, attention was paid
to include the rostral part of the thalamus, the midbrain, the pons,
the medulla oblongata, the fourth ventricle, and the cerebellar
vermis (Fig 2A).
3D Technique. After a standard 2D examination, 3D volumes
were acquired for off-line computer evaluation.10 Before we
acquired the volume, the contrast of the 2D image was opti-
mized by activating the harmonic function with high fre-
quency, low gain, and high contrast, to enhance tissue inter-
faces. The 3D image was acquired during fetal rest in the
absence of fetal movements, and the standard volume sweep
angle was 55°. The starting image was in the axial plane at the
level of the transverse cerebellar diameter. The static VCI on
plane C was rebuilt, and a perfect midsagittal view was ob-
tained. Subsequently, the volume measurements were stored,
and analysis was performed off-line with 4D View, Version 7.0
software (GE Healthcare, Kretz Ultrasound).
After obtaining a measurement of the volume of the fetal brain
in the axial plain, we placed the reference dot in the A reference
image in the middle of the vermis. Afterward, the skull was rotated
along the z-axis until the midline was horizontal, and the dot of
interest was placed in the middle of the vermis in the B reference
image. Finally, the skull was rotated again along the z-axis until
the midline was again horizontal. The image was magnified to the
maximal size available, and biometric measurements were per-
formed (Fig 2B).
MR Imaging. Scans were obtained by using a 1.5T system (Op-
tima; GE Healthcare). Single-shot fast spin-echo T2-weighted
sequences in 3 orthogonal planes were performed with the follow-
ing parameters: section thickness, 3 mm; no gap; flexible coil (8-
channel cardiac coil); matrix, 320/224; TE, 90 ms; and TR, 1298
ms. The FOV was determined by the size of the fetal head and was
24 cm for the smaller fetuses and up to 30 cm for the larger fetuses.
T1 fast spoiled gradient-echo sequences were performed only in
the axial plane with a larger FOV (400 mm); section thickness, 3
mm; gap, 0.5 mm; TR, 160 ms; TE, 2.3 ms. Then diffusion-
weighted sequences in the axial plane were performed with an
FOV, 40 cm; b-value, 0 and 1000 ms; section thickness, 3 mm; and
no gap.
Table 5: Linear association between gestational age and
biometric measurements
Linear Regression Coefficient Model Summary
Unstandardized a Standardized  Adjusted R2
SI
US 2D 0.693 0.916 0.839
US 3D 0.833 0.899 0.806
MRI 0.742 0.811 0.656
AP
US 2D 0.559 0.871 0.757
US 3D 0.574 0.800 0.637
MRI 0.606 0.791 0.624
Perimeter
US 2D 2.340 0.912 0.831
US 3D 2.989 0.889 0.790
MRI 3.243 0.843 0.708
SA
US 2D 18.487 0.948 0.897
US 3D 19.670 0.897 0.804
MRI 17.587 0.844 0.711
a P  .001 for all coefficients.
Table 6: Comparison of imaging modalities for each biometric measurement: estimated marginal means 95% CI
SI AP Perimeter SA
Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI
At gestational age 29.6 wka
US 2D 18.10 17.91–18.30 12.99 12.80–13.19 63.34 62.60–64.08 247.45 243.13–251.77
US 3D 19.80 19.58–20.01 13.18 12.97–13.39 67.77 66.97–68.5 258.43 253.77–263.10
MRI 16.47 16.23–16.70 11.40 11.17–11.64 60.68 59.80–61.55 181.04 175.90–186.1
For examinations preformed at 27 wk
of gestation: mean gestational age, 31.3 wk
US 2D 19.28 19.05–19.51 13.88 13.64–14.11 67.20 66.31–68.10 276.99 271.53–282.45
US 3D 17.80 17.57–18.03 12.36 12.13–12.59 65.34 64.48–66.20 212.94 207.68–218.20
MRI 21.34 21.08–21.61 14.20 13.93–14.46 73.28 72.28–74.29 294.12 288.00–300.23
a Mean gestational age for all populations (516 fetuses).
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The biometric parameters of the fetal vermis were measured in
the midsagittal plane by using single-shot fast spin-echo T2-
weighted sequences (Fig 2C).
Statistical Analysis
Statistical analysis was performed with the SPSS software, Version
22.0 (IBM, Armonk, New York). Gestational age was described as
mean, median, and range. Biometric measurements of the vermis
are described for each gestational age as median and 5th and 95th
percentiles and as mean  SD and 95% CI of the mean. Linear
regression models were used to assess the relationship between
gestational age and vermian biometric measurements.
Comparison among the 3 imaging modalities for each biomet-
ric measurement adjusted for gestational age was performed by
using a general linear model with the Bonferroni multiple com-
parison test. Because MR imaging was not performed before 27
weeks’ gestational age, a sensitivity analysis was added consider-
ing MR imaging, US 2D, and US 3D measurements at the gesta-
tional age of 27 weeks. Estimates of the intraclass correlation
coefficient (ICC) were used to explore inter- and intra-agreement
between the radiologists. Agreement was considered slight with
ICC  0.2, fair with 0.2 
ICC  0.4, moderate with
0.4  ICC  0.6, substantial
with 0.6  ICC  0.8, and al-
most perfect with ICC  0.8.
Ethics Approval
The study was approved by
the institutional review board




The study groups included
516 fetuses with a normal pos-
terior fossa: 193 in the US 2D
group (range, 21–35 weeks of
gestation; mean, 29.1 weeks;
median, 29.5 weeks), 172 in
the US 3D group (range,
21–35 weeks of gestation;
mean, 28.2 weeks; median,
29.05 weeks), and 151 fetuses
in the MR imaging group
(range, 27–35 weeks of gesta-
tion, mean, 32.1 weeks; me-
dian, 32.6 weeks).
Biometric measurements
of the vermis are described for
each parameter, imaging mo-
dality, and gestational age as
median and 5th and 95th per-
centiles (Tables 1– 4) and as
mean  SD and 95% CI of the
mean (Fig 3 and On-line Ta-
bles 1– 4). For all 3 imaging
modalities, the biometric measurements of the vermis have
shown a linear growth with gestational age. Results from linear
regression models are presented in Table 5.
When we compared the effect of imaging technique controlled
for gestational age in the general linear model, the lowest results
were those measured by MR imaging, while the highest results
were measured by 3D US. All the differences (Bonferroni com-
parison) were significant (P  .001) except AP and surface area
(SA) measurements by 2D and 3D US (P  .601 and .02) (Table 6
and On-line Tables 5 and 6).
Reproducibility of Measurements
Reproducibility of measurement was excellent for all measures
and all imaging modalities (Tables 7 and 8), The limits of
agreement were considered acceptable for clinical purposes for
all parameters, with excellent or substantial agreement defined
by ICC.
DISCUSSION
The differential diagnosis of vermian pathology is quite challeng-
ing. Biometric parameters allow assessment of the integrity of the
Table 7: Intraobserver reproducibility of measurements
Vermian Measurement
Differences in Measurements of
Vermian Biometry
Mean (95% CI of the Difference) ICC (95% CI)
US 2D, intraobserver variability
SI 0.34  0.73 (0.54 to 0.13) 0.94 (0.91 to 0.97)
AP 0.71  1.02 (0.42 to 1.00) 0.85 (0.75 to 0.91)
Perimeter 0.93  2.7 (0.16 to 1.7) 0.93 (0.88 to 0.96)
SA 2.2  14.4 (2.04 to 1.81) 0.97 (0.95 to 0.98)
US 3D, interobserver variability
SI 0.47  1.5 (0.89 to 0.43) 0.95 (0.92 to 0.97)
AP 0.26  0.55 (0.41 to 0.10) 0.98 (0.98 to 0.99)
Perimeter 1.05  10.66 (1.97 to 4.08) 0.81 (0.7 to 0.89)
SA 1.2  2.6 (1.95 to 0.44) 0.999 (0.99 to 1.0)
MRI, intraobserver variability
SI 0.60  0.66 (0.42 to 0.79) 0.94 (0.91 to 0.97)
AP 0.55  1.05 (0.25 to 0.85) 0.79 (0.66 to 0.88)
Perimeter 1.2  4.05 (0.05 to 2.3) 0.88 (0.81 to 0.93)
SA 0.36  10.1 (3.2 to 2.5) 0.97 (0.96 to 0.98)
Table 8: Interobserver reproducibility of measurements
Vermian Measurement
Differences in Measurements of
Vermian Biometry
Mean (95% CI of the Difference) ICC (95% CI)
US 2D, interobserver variability
SI 0.07  1.15 (0.40 to 0.25) 0.86 (0.77 to 0.92)
AP 0.92  1.32 (0.54 to 1.2) 0.71 (0.54 to 0.82)
Perimeter 2.4  4.6 (1.15 to 3.81) 0.81 (0.69 to 0.88)
SA 8.3  31.18 (0.47 to 17.25) 0.86 (0.76 to 0.91)
US 3D, interobserver variability
SI 0.07  1.15 (0.40 to 0.25) 0.86 (0.77 to 0.92)
AP 0.92  1.32 (0.54 to 1.2) 0.71 (0.54 to 0.82)
Perimeter 2.4  4.6 (1.15 to 3.81) 0.81 (0.69 to 0.88)
SA 8.3  31.18 (0.47 to 17.25) 0.86 (0.76 to 0.91)
MRI, interobserver variability
SI 0.47  1.5 (0.89 to 0.43) 0.95 (0.92 to 0.97)
AP 0.26  0.55 (0.41 to 0.10) 0.98 (0.98 to 0.99)
Perimeter 1.05  10.66 (1.97 to 4.08) 0.81 (0.7 to 0.89)
SA 1.2  2.6 (1.95 to 0.44) 0.99 (0.99 to 1.0)
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vermis, especially in cases in which the main anatomic landmarks
cannot be well demonstrated.
This study provides vermian biometric data from a large
cohort of fetuses from 21 to 35 weeks of gestation assessed by 3
imaging modalities. So far, although various nomograms have
been developed by using 2D and 3D sonography and MR im-
aging,17-19 none has provided data regarding all 4 vermian pa-
rameters (maximum superoinferior diameter, maximum an-
teroposterior diameter, perimeter, and surface area) or
compared measurements obtained by the 3 modalities. More-
over, it was not clear whether measurements obtained by dif-
ferent modalities can be compared for clinical purposes.
Biometric analysis of the vermis has a major role in the evalu-
ation of an abnormal posterior fossa for precise prenatal diagno-
sis. With this study, we provide new reference data for 3 imaging
modalities for the biometric parameters.
2D US is the major tool used in customary clinical work and
serves as an excellent screening tool for the diagnosis of an abnor-
mal posterior fossa.1 However, at advanced gestation, acoustic
shadow from the bony fetal skull and the bony maternal pelvis
make the transabdominal visualization and measurement of the
vermis challenging; therefore, transvaginal US is frequently
needed for clear imaging of the fetal vermis. This approach is
obviously not relevant in breech presentations.
3D US imaging has 3 major advantages. The first is the ability
to easily reconstruct the relevant midsagittal plane from the axial
plane independent of fetal lie and position. The second is the
ability to store data and perform postprocessing off-line analysis.
This feature allows filter application such as static VCI to achieve
improved tissue contrast and better visualization of anatomic
landmarks.11,21 The third advantage is the ability to depict poste-
rior fossa anomalies during early gestational ages.22
MR imaging has an advantage in brain imaging at advanced
gestational age. Unlike 2D US and 3D US, MR imaging provides
high-resolution images almost independent of maternal body
habitus and fetal position. Moreover, MR imaging provides the
opportunity of diagnosing associated brain abnormalities, such as
migration disorders, white matter abnormalities, and so forth.
In this study for all 3 imaging modalities, the biometric mea-
surements of the vermis have shown a linear growth with gesta-
tional age.
Statistically significant differences among imaging modalities
justify applying a technique-specific reference value for fetal ver-
mis measurements. The differences between measurements can
be explained by a clearer image of the fetal vermis borders ob-
tained by MR imaging, in comparison with the relatively blurred
borders obtained by 3D US.
Reproducibility of measurements, expressed by inter- and in-
traobserver variability and the ICC, is not always evaluated in
articles providing reference data for fetal brain measure-
ments.23,24 Our study showed high intraobserver reproducibility
(range, 0.79 – 0.99) and high agreement between 2 radiologists
(range, 0.71–1) for all biometric measurements in the 3 imag-
ing modalities. Similar results were reported by Tilea et al18
and by Ber et al25 for MR imaging measurements of the poste-
rior fossa.
CONCLUSIONS
Overall, our study provides normal biometric data of the fetal
vermis in a large cohort of fetuses from 21 to 35 weeks of gestation
in 3 imaging modalities. Statistical analysis revealed high inter-
and intraobserver reproducibility of measurements. Differences
in biometric measurements between imaging modalities justify
applying technique-specific reference values for fetal vermis mea-
surements. The nomograms developed in this study may have a
role in the multidisciplinary clinically challenging prenatal classi-
fication of an abnormal posterior fossa.
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